Cabozantinib
|
- $7 - $2167
- Product name: Cabozantinib
- CAS: 849217-68-1
- MF: C28H24FN3O5
- MW: 501.51
- EINECS:692-846-8
- MDL Number:MFCD20926324
- Synonyms:Cabozantinib(XL184Malate);Cabozantinib (XL184, BMS-907351);XL-186;1,1-cyclopropanedicarboxamide, n'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-n-(4-fluorophenyl)-;N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide Cabozantinib (XL184, BMS-907351);Cabozantinib, >=98%;1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Cabozantinib
74 prices
Selected condition:
Brand
- aablocks
- ACHEMBLOCK
- Adipogen Life Sciences
- AK Scientific
- Ambeed
- American Custom Chemicals Corporation
- ApexBio Technology
- Arctom
- AvaChem
- Biorbyt Ltd
- Biosynth
- Cayman Chemical
- ChemScene
- DC Chemicals
- Matrix Scientific
- Tocris
- TRC
- Usbiological
Package
- 20mg
- 25mg
- 500mg
- 10mM(in1mLDMSO)
- 1.00g
- 50
- 10
- 10mM*1mLinDMSO
- 1000mg
- 2000mg
- EvaluationSample
- 1mg
- 5mg
- 10mg
- 50mg
- 100mg
- 200MG
- 250mg
- 1g
- 5g
- 10g
- Manufactureraablocks
- Product numberAA003A5Y
- Product descriptionN'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98%
- Packaging1mg
- Price$8
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA003A5Y
- Product descriptionN'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98%
- Packaging100mg
- Price$18
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA003A5Y
- Product descriptionN'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98%
- Packaging250mg
- Price$27
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA003A5Y
- Product descriptionN'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98%
- Packaging1g
- Price$52
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA003A5Y
- Product descriptionN'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98%
- Packaging5g
- Price$166
- Updated2026-05-28
- Buy
- ManufacturerACHEMBLOCK
- Product numberG-6215
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 97%
- Packaging5G
- Price$135
- Updated2026-05-27
- Buy
- ManufacturerACHEMBLOCK
- Product numberG-6215
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 97%
- Packaging1G
- Price$50
- Updated2026-05-27
- Buy
- ManufacturerAdipogen Life Sciences
- Product numberCDX-C0755-M010
- Product descriptionCabozantinib ≥98%(HPLC)
- Packaging10mg
- Price$145
- Updated2026-05-06
- Buy
- ManufacturerAdipogen Life Sciences
- Product numberCDX-C0755-M050
- Product descriptionCabozantinib ≥98%(HPLC)
- Packaging50mg
- Price$460
- Updated2026-05-06
- Buy
- ManufacturerAdipogen Life Sciences
- Product numberSYN-1138-M050
- Product descriptionCabozantinib ≥95%
- Packaging50mg
- Price$497
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product numberSYN1138
- Product descriptionCabozantinib
- Packaging100mg
- Price$845
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product numberSYN1138
- Product descriptionCabozantinib
- Packaging10mg
- Price$190
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA200488
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+%
- Packaging250mg
- Price$65
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA200488
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+%
- Packaging50mg
- Price$12
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA200488
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+%
- Packaging100mg
- Price$15
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA200488
- Product descriptionN-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+%
- Packaging10mg
- Price$7
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA003A5Y | N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98% | 1mg | $8 | 2026-05-28 | Buy |
| aablocks | AA003A5Y | N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98% | 100mg | $18 | 2026-05-28 | Buy |
| aablocks | AA003A5Y | N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98% | 250mg | $27 | 2026-05-28 | Buy |
| aablocks | AA003A5Y | N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98% | 1g | $52 | 2026-05-28 | Buy |
| aablocks | AA003A5Y | N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide 98% | 5g | $166 | 2026-05-28 | Buy |
| ACHEMBLOCK | G-6215 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 97% | 5G | $135 | 2026-05-27 | Buy |
| ACHEMBLOCK | G-6215 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 97% | 1G | $50 | 2026-05-27 | Buy |
| Adipogen Life Sciences | CDX-C0755-M010 | Cabozantinib ≥98%(HPLC) | 10mg | $145 | 2026-05-06 | Buy |
| Adipogen Life Sciences | CDX-C0755-M050 | Cabozantinib ≥98%(HPLC) | 50mg | $460 | 2026-05-06 | Buy |
| Adipogen Life Sciences | SYN-1138-M050 | Cabozantinib ≥95% | 50mg | $497 | 2021-12-16 | Buy |
| AK Scientific | SYN1138 | Cabozantinib | 100mg | $845 | 2021-12-16 | Buy |
| AK Scientific | SYN1138 | Cabozantinib | 10mg | $190 | 2021-12-16 | Buy |
| Ambeed | A200488 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+% | 250mg | $65 | 2021-12-16 | Buy |
| Ambeed | A200488 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+% | 50mg | $12 | 2021-12-16 | Buy |
| Ambeed | A200488 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+% | 100mg | $15 | 2021-12-16 | Buy |
| Ambeed | A200488 | N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 98+% | 10mg | $7 | 2021-12-16 | Buy |
Properties
Melting point :212-215°C
Boiling point :758.1±60.0 °C(Predicted)
Density :1.396
storage temp. :-20°C
solubility :Soluble in DMSO
form :White powder.
pka :13.86±0.70(Predicted)
color :White
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey :ONIQOQHATWINJY-UHFFFAOYSA-N
SMILES :C1(C(NC2=CC=C(OC3C4C(N=CC=3)=CC(OC)=C(OC)C=4)C=C2)=O)(C(NC2=CC=C(F)C=C2)=O)CC1
Boiling point :758.1±60.0 °C(Predicted)
Density :1.396
storage temp. :-20°C
solubility :Soluble in DMSO
form :White powder.
pka :13.86±0.70(Predicted)
color :White
Stability :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
InChIKey :ONIQOQHATWINJY-UHFFFAOYSA-N
SMILES :C1(C(NC2=CC=C(OC3C4C(N=CC=3)=CC(OC)=C(OC)C=4)C=C2)=O)(C(NC2=CC=C(F)C=C2)=O)CC1
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|
Description
XL184 is a pan tyrosine kinase inhibitor that primarily targets VEGFR2 (IC50 = 0.035 nM) and c-Met (IC50 = 1.3 nM) but also inhibits RET, c-Kit, Axl, FLT3, and Tie2 (IC50s = 5.2, 4.6, 7, 11.3, and 14.3 nM, respectively). In in vivo breast, lung, and glioma tumor models that represent dysregulated c-Met and VEGFR signaling, XL184 was shown to reduce tumor and endothelial cell proliferation, inhibiting both angiogenesis and metastasis. XL184 has undergone clinical trial in a broad number of cancers, including thyroid carcinoma, prostate cancer, ovarian cancer, melanoma, breast cancer, non-small cell lung cancer, hepatocellular cancer, renal cell carcinoma, and glioblastoma.Related product price
-
Foretinib (GSK1363089)
$12-9455 -
Crizotinib
$5-1963.5 -
Sunitinib Malate
$6-1593.9
Suppliers and manufacturers
Changzhou Borl Biotechnology Co.,LTD
Jinan Chuanbei Biotechnology Co., Ltd
Hangzhou Runyan Medical Technology Co., LTD
Zhengzhou Science Pharmaceutical Technology Co., Ltd
Tianjin Famoxi Biopharmaceutical Technology Co., Ltd
Shanghai Boyle Chemical Co., Ltd.
ChemFuture PharmaTech (Jiangsu) Ltd
Chembest Research Laboratories Limited
Beijing HwrkChemical Technology Co., Ltd
JinYan Chemicals(ShangHai) Co.,Ltd.




